tiprankstipranks
Trending News
More News >
Lineage Cell Therapeutics, Inc. (GB:0HNF)
LSE:0HNF

Lineage Therap (0HNF) Revenue

Compare
2 Followers

Lineage Therap Revenue

Lineage Therap had a revenue of 1.50M in the quarter ending Mar 31, 2025, with -47.63%. This bring the company's revenue in the last twelve months to 9.56M, Decreased 0.61%. In the fiscal year ending Dec 31, 2024, Lineage Therap had annual revenue of 9.50M with 6.19% growth.
Revenue (ttm)
9.56M
Revenue Growth
P/S Ratio
16.80
Revenue/Employee
$135,700
Employees
70
Market Cap
$159.55M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
9.50M554.00K+6.19%
Dec 31, 2023
8.95M-5.76M-39.16%
Dec 31, 2022
14.70M10.81M+277.39%
Dec 31, 2021
3.90M3.12M+404.01%
Dec 31, 2020
773.00K-705.00K-47.70%
Dec 31, 2019
1.48M62.00K+4.38%
Dec 31, 2018
1.42M-376.00K-20.98%
Dec 31, 2017
1.79M-460.00K-20.43%
Dec 31, 2016
2.25M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis